From: Kathy Ruemmler Sent: Tuesday, November 22, 2016 1:32 PM To: Jeffrey E. Subject: Fwd: Begin forwarded=message: From: =ate: November 22, 2016 at 8:30:34 AM EST To: =/blockquote> The National Law Journal Mylan Won't Testify at EpiP=n Hearing, Drawing Chuck Grassley's Ire<http://www.nationallawjourna=.com/id=1202772942932/Mylan-Wont-Testify-at-EpiPen-Hearing-Drawing-Chuck- =rassleys-lre?slreturn=20161022074622 <http://www.nationalla=journal.com/id=1202772942932/Mylan-Wont-Testify- at-EpiPen-Hearing-Drawing=Chuck-Grassleys-lre?slreturn=20161022074622» November 21,=2016 Obama administration officials and Mylan N.V. are decl=ning to send representatives to testify at a Senate Judiciary Committee hea=ing this month that would explore the government's $465 million set=lement with the pharmaceutical company over its alleged misclassification o= the life-saving device EpiPen for purposes of Medicaid rebates. =span>Sen. Chuck Grassley, R-Iowa, chairman of Senate Judiciary, has questio=ed the fairness<http://www.law.comMtes/almstaff/2016/10/11/mylans-465m-epipen-settlement-unlikely-to-end-scru=iny/ <http://www.law.com/sites/almstaff/2016/10/11/=ylans-465m-epipen-settlement-unlikely-to-end-scrutiny/» of the deal that Mylan said it had reached in October with therU.S. Justice Department and regulatory agencies. The settlement, which Myla= announced in a news release<http://newsroom.mylan.com/2016-10-07-Mylan-Agrees-to- Settlem=nt-on-Medicaid-Rebate-Classification-for-EpiPen-Auto-Injector chttp://newsroom.mylan.com/2016-1=-07- Mylan-Agrees-to-Settlement-on-Medicaid-Rebate-Classification-for-EpiPen=Auto-Injector», came=amid the public outcry over Mylan's decision to increase the price o= its epinephrine auto-injector EpiPen. The Justice Departme=t and Centers for Medicaid and Medicare Services haven't commented o= the settlement. Mylan didn't admit any wrongdoing. Grassley0=99s full statement: The Obama administration is dodging acc=untability for